- Investing Ideas
- /
- U.S. Top Growth Stocks
U.S. Top Growth Stocks
Results
105
105 companies
Infinity Natural Resources
Market Cap: US$859.0m
Engages in the acquisition, exploration, and development of properties to produce oil, natural gas, and natural gas liquids from underground reservoirs in the United States.
INR
US$14.11
7D
-5.3%
1Y
n/a
Axsome Therapeutics
Market Cap: US$6.2b
A biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in the United States.
AXSM
US$125.17
7D
3.2%
1Y
33.0%
Zevra Therapeutics
Market Cap: US$502.4m
A commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States.
ZVRA
US$8.95
7D
-1.3%
1Y
23.8%
NVIDIA
Market Cap: US$4.1t
A computing infrastructure company, provides graphics and compute and networking solutions in the United States, Singapore, Taiwan, China, Hong Kong, and internationally.
NVDA
US$167.02
7D
-4.1%
1Y
56.9%
Atour Lifestyle Holdings
Market Cap: US$5.4b
Through its subsidiaries, develops lifestyle brands around hotel offerings in the People’s Republic of China.
ATAT
US$39.04
7D
0.3%
1Y
105.5%
Niu Technologies
Market Cap: US$338.4m
Designs, manufactures, and sells electric scooters in the People's Republic of China, Europe, and internationally.
NIU
US$4.34
7D
-0.7%
1Y
142.5%
D-Market Elektronik Hizmetler ve Ticaret
Market Cap: US$903.1m
D-Market Elektronik Hizmetler ve Ticaret A.S.
HEPS
US$2.81
7D
1.8%
1Y
4.1%
Legend Biotech
Market Cap: US$6.7b
Through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe.
LEGN
US$36.08
7D
3.9%
1Y
-28.4%
Luckin Coffee
Market Cap: US$11.7b
Offers retail services of freshly brewed drinks, and pre-made food and beverage items in the People's Republic of China.
LKNC.Y
US$36.50
7D
-1.9%
1Y
85.3%
Financial Institutions
Market Cap: US$552.6m
Through its subsidiaries, provides banking and financial services to consumer, commercial, and municipal customers in New York.
FISI
US$27.45
7D
-0.8%
1Y
9.8%
Excelerate Energy
Market Cap: US$2.7b
Provides liquefied natural gas (LNG) solutions worldwide.
EE
US$23.70
7D
-2.9%
1Y
28.0%
Intchains Group
Market Cap: US$107.2m
Engages in the provision of altcoin mining products in the People’s Republic of China.
ICG
US$1.77
7D
-6.8%
1Y
-73.7%
Evoke Pharma
Market Cap: US$10.9m
Operates as a specialty pharmaceutical company that focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases.
EVOK
US$5.21
7D
-4.4%
1Y
26.8%
Soleno Therapeutics
Market Cap: US$3.7b
A clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases.
SLNO
US$69.77
7D
3.1%
1Y
43.1%
ADMA Biologics
Market Cap: US$4.0b
A biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.
ADMA
US$16.87
7D
-2.3%
1Y
-8.2%
Remitly Global
Market Cap: US$4.0b
Engages in the provision of digital financial services in the United States, Canada, and internationally.
RELY
US$19.49
7D
5.2%
1Y
42.2%
Workday
Market Cap: US$61.7b
Provides enterprise cloud applications in the United States and internationally.
WDAY
US$231.08
7D
0.1%
1Y
-8.9%
EHang Holdings
Market Cap: US$1.2b
Operates as an urban air mobility (UAM) technology platform company in the People’s Republic of China, East Asia, West Asia, North America, South America, West Africa, and Europe.
EH
US$16.16
7D
2.1%
1Y
38.5%
Delcath Systems
Market Cap: US$407.5m
An interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe.
DCTH
US$11.65
7D
5.7%
1Y
19.1%
Ryan Specialty Holdings
Market Cap: US$14.3b
Operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, rest of Europe, India, and Singapore.
RYAN
US$54.39
7D
-3.8%
1Y
-14.8%
Similarweb
Market Cap: US$824.9m
Provides digital data and analytics for power critical business decisions in the United States, Europe, the Asia Pacific, the United Kingdom, Israel, and internationally.
SMWB
US$9.72
7D
-6.4%
1Y
8.1%
Chemung Financial
Market Cap: US$250.6m
Operates as a bank holding company for Chemung Canal Trust Company that provides a range of banking, financing, fiduciary, and other financial services.
CHMG
US$52.31
7D
-3.0%
1Y
12.7%
A2Z Cust2Mate Solutions
Market Cap: US$307.6m
A technology company, focuses on the development and commercialization of retail smart cart solutions for grocery stores and supermarkets in Israel and internationally.
AZ
US$8.54
7D
-3.7%
1Y
518.7%
ARS Pharmaceuticals
Market Cap: US$995.2m
A biopharmaceutical company, develops and commercializes treatments for severe allergic reactions.
SPRY
US$10.07
7D
-13.3%
1Y
-14.0%
Achieve Life Sciences
Market Cap: US$144.6m
A late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom.
ACHV
US$2.83
7D
-5.0%
1Y
-34.0%
Plumas Bancorp
Market Cap: US$311.2m
Operates as the bank holding company for the Plumas Bank that provides various banking products and services for small and middle market businesses and individuals in California, Nevada, and Oregon.
PLBC
US$44.80
7D
3.2%
1Y
11.0%
Vanda Pharmaceuticals
Market Cap: US$272.4m
A biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs worldwide.
VNDA
US$4.61
7D
-2.5%
1Y
-8.2%
Madrigal Pharmaceuticals
Market Cap: US$9.6b
A biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States.
MDGL
US$432.89
7D
-1.1%
1Y
81.4%
ACADIA Pharmaceuticals
Market Cap: US$4.3b
A biopharmaceutical company, focuses on the development and commercialization of medicines for central nervous system (CNS) disorders and rare diseases in the United States.
ACAD
US$25.26
7D
-2.8%
1Y
60.2%
XPeng
Market Cap: US$18.9b
Designs, develops, manufactures, and markets smart electric vehicles (EVs) in the People’s Republic of China.
XPEV
US$19.83
7D
-5.7%
1Y
132.7%
CNB Financial
Market Cap: US$761.2m
Operates as the bank holding company for CNB Bank that provides various banking products and services for individual, business, governmental, and institutional customers.
CCNE
US$26.05
7D
-1.0%
1Y
12.8%
Arcutis Biotherapeutics
Market Cap: US$2.1b
A biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases.
ARQT
US$17.15
7D
10.5%
1Y
59.2%
ATRenew
Market Cap: US$973.6m
Operates pre-owned consumer electronics transactions and services platform in the People’s Republic of China.
RERE
US$4.36
7D
-7.6%
1Y
82.4%
AC Immune
Market Cap: US$225.6m
A clinical stage biopharmaceutical company, discovers, designs, and develops medicines, and therapeutic and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding.
ACIU
US$2.28
7D
11.8%
1Y
-25.2%
Simmons First National
Market Cap: US$3.0b
Operates as the bank holding company for Simmons Bank that provides banking and other financial products and services to individuals and businesses.
SFNC
US$20.88
7D
0.5%
1Y
1.7%
CorMedix
Market Cap: US$925.6m
A biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.
CRMD
US$12.40
7D
-16.4%
1Y
121.4%